Amgen’s Deal for Horizon Therapeutics Clears Key Hurdle
The Wall Street JournalThe Federal Trade Commission said it had agreed to end its legal challenge of the $27.8 billion deal. The pact also dismisses the antitrust claims of six states that joined the FTC in seeking to block the transaction.